Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Dermatology|January 13, 2026
Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian StudyEleonora De Luca, Annunziata Dattola, Fabio Artosi, et al.
Journal of Clinical Medicine|January 23, 2024
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS)Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, et al.
The Journal of Dermatological Treatment|January 6, 2025
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world studyCarlo A Vignoli, Luigi Gargiulo, Luciano Ibba, et al.
International Journal of Dermatology|April 18, 2026
Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective StudyLuca Bettolini, Carlo Alberto Maronese, Federica Derlino, et al.
Archives of Dermatological Research|May 23, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis)Luca Potestio, Cataldo Patruno, Alessandra Narcisi, et al.
American Journal of Clinical Dermatology|February 24, 2025
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter StudyFrancesco Leo, Michela Ortoncelli, Ruggero Cascio Ingurgio, et al.
The Journal of Dermatology|April 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort StudyGianluca Avallone, Carlo Alberto Maronese, Martina Zussino, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Clinical and Experimental Dermatology|November 1, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)Diego Orsini, Luca Potestio, Maria Concetta Fargnoli, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
Pageof 8